Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.
作者信息
Johnson P J, Wansbrough-Jones M H, Portmann B, Eddleston A L, Williams R, Maycook W D, Calne R Y
出版信息
Br Med J. 1978 Jan 28;1(6107):216. doi: 10.1136/bmj.1.6107.216.
Abstract
摘要
相似文献
1
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.家族性乙肝表面抗原阳性肝癌：原位肝移植及特异性免疫球蛋白治疗
Br Med J. 1978 Jan 28;1(6107):216. doi: 10.1136/bmj.1.6107.216.
2
[Familial hepatocellular carcinoma with positive surface antigen (HBsAg)].
Med Clin (Barc). 1985 Dec 14;85(20):859.
3
Liver transplantation in a 27-year-old female with familial HBsAg-positive hepatocellular carcinoma.
Neth J Med. 1978;21(3):101-16.
4
Serum Gm system in liver cirrhosis and hepatoma.肝硬化和肝癌中的血清Gm系统
Hum Genet. 1980;56(2):217-9. doi: 10.1007/BF00295698.
5
Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.
Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):345-8.
6
HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.乙肝表面抗原阳性的原发性肝细胞癌患者血清中的乙肝病毒脱氧核糖核酸
Z Gastroenterol. 1984 Apr;22(4):182-7.
7
Hepatitis B virus infection and chronic liver disease in Taiwan.台湾的乙型肝炎病毒感染与慢性肝病
Acta Hepatogastroenterol (Stuttg). 1978 Dec;25(6):423-30.
8
Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases.尸检病例肝脏石蜡切片中乙肝表面抗原的地衣红染色
Acta Hepatogastroenterol (Stuttg). 1977 Oct;24(5):334-9.
9
HLA antigen in Chinese patients with hepatocellular carcinomas.中国肝细胞癌患者的人类白细胞抗原
J Natl Cancer Inst. 1980 Jul;65(1):21-3.
10
Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.核苷（酸）类似物联合乙型肝炎免疫球蛋白停药用于肝移植后慢性乙型肝炎是安全有效的。
J Clin Virol. 2013 Sep;58(1):67-73. doi: 10.1016/j.jcv.2013.06.035. Epub 2013 Jul 20.
引用本文的文献
1
Safe and cost-effective control of post-transplantation recurrence of hepatitis B.安全且具成本效益的肝移植后乙肝复发控制
Hepatol Res. 2015 Jan;45(1):38-47. doi: 10.1111/hepr.12368. Epub 2014 Jul 18.
2
Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation.肝移植后预防乙型肝炎病毒再感染的预防性方案的网状荟萃分析。
Hepatobiliary Surg Nutr. 2013 Dec;2(6):297-303. doi: 10.3978/j.issn.2304-3881.2013.11.02.
3
Hepatitis B virus infection in liver transplant candidates and recipients.肝移植候选者及接受者中的乙型肝炎病毒感染
MedGenMed. 2005 Apr 18;7(2):20.
4
Liver transplantation for liver cancer.肝癌的肝移植
World J Surg. 1982 Jan;6(1):76-80. doi: 10.1007/BF01656376.
5
Improved survival after orthotopic liver grafting.原位肝移植后生存率提高。
Br Med J (Clin Res Ed). 1981 Jul 11;283(6284):115-8. doi: 10.1136/bmj.283.6284.115.
6
Evolution of liver transplantation.肝移植的发展历程。
Hepatology. 1982 Sep-Oct;2(5):614-36. doi: 10.1002/hep.1840020516.
7
Clustering of hepatitis B virus infection and hepatocellular carcinoma in a family.一个家族中乙型肝炎病毒感染与肝细胞癌的聚集现象。
J R Soc Med. 1981 Nov;74(11):843-5. doi: 10.1177/014107688107401114.
8
Hepatic transplantation.
Springer Semin Immunopathol. 1980 Dec;3(3):385-93. doi: 10.1007/BF02054112.
9
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.肝移植后乙型肝炎病毒肝病的演变。实践与理论思考。
Am J Pathol. 1990 Sep;137(3):667-76.
10
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.乙型肝炎病毒相关肝病患者的原位肝移植
Hepatology. 1991 Apr;13(4):619-26.
本文引用的文献
1
Familial hepatoma with hepatitis-associated antigen.
Ann Intern Med. 1971 Mar;74(3):391-4. doi: 10.7326/0003-4819-74-3-391.
2
Primary hepatocellular carcinoma in three male siblings.
Cancer. 1968 Jul;22(1):142-50. doi: 10.1002/1097-0142(196807)22:1<142::aid-cncr2820220117>3.0.co;2-4.
3
Orthotopic liver transplantation: the first 60 patients.原位肝移植：首批60例患者
Br Med J. 1977 Feb 19;1(6059):471-6. doi: 10.1136/bmj.1.6059.471.
Zotero 插件